A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

clinical trial

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02443155

P6099clinical trial phasephase II clinical trialQ42824440
P17countryCanadaQ16
NorwayQ20
Republic of IrelandQ27
SpainQ29
United States of AmericaQ30
BelgiumQ31
FinlandQ33
SwedenQ34
DenmarkQ35
ItalyQ38
PolandQ36
AustriaQ40
PortugalQ45
United KingdomQ145
UkraineQ212
SerbiaQ403
IsraelQ801
P582end time2018-08-31
P4135maximum age45
P1050medical conditiondiabetesQ12206
P2899minimum age18
P1132number of participants308
P4844research interventionliraglutideQ2526479
P6153research siteNovo NordiskQ818846
P580start time2015-11-10
P8363study typeinterventional studyQ78089383
P1476titleA Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Multi-centre Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Search more.